Fig. 4From: MUC1 in lung adenocarcinoma: cross-sectional genetic and serological studySerum KL-6 can predict the outcome of patients with lung adenocarcinoma. Receiver operating characteristic curves for (a) 1-year, (b) 3-year, and (c) 5-year survival. The Kaplan-Meier survival curves for each cohort stratified by the two different cut-off value of serum KL-6; (d) 600Â U/mL (set by ROC analyses), (e) 334Â U/mL (median value)Back to article page